Moderna Inc

NASDAQ:MRNA   3:59:59 PM EDT
440.88
+6.42 (+1.48%)
4:59:53 PM EDT: $440.36 -0.52 (-0.12%)
Products

Moderna Notified Of Cases Of Particulate Matter Seen In Vials Of Covid-19 Vaccine For A Lot Distributed In Japan

Published: 08/25/2021 22:35 GMT
Moderna Inc (MRNA) - Moderna Confirms Having Been Notified of Cases of Particulate Matter Being Seen in Drug Product Vials Associated With 1 Lot Distributed in Japan of Covid-19 Vaccine.
Moderna Says Has Put One Product Lot Distributed in Japan and Two Adjacent Lots on Hold.
Moderna Says Investigating Reports of Cases of Particulate Matter Being Seen in Drug Product Vials of Its Covid-19 Vaccine in 1 Lot Distributed in Japan.
Moderna - Believes Manufacturing Issue Related to Particulate Matter Seen in Vials of Covid-19 Vaccine Generated in One Line Used at Contract Manufacturing Site in Spain.
Moderna - No Safety/efficacy Issues Have Been Identified Related to Cases of Particulate Matter Seen in Drug Product Vials of Covid-19 Vaccine in Japan.
Further Company Coverage: Mrnao ((reuters.
Briefs@thomsonreuters.
Com;)).